Cargando…
5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro
The current COVID-19 pandemic requires urgent development of effective therapeutics. 5-amino levulinic acid (5-ALA) is a naturally synthesized amino acid and has been used for multiple purposes including as an anticancer therapy and as a dietary supplement due to its high bioavailability. In this st...
Autores principales: | Sakurai, Yasuteru, Ngwe Tun, Mya Myat, Kurosaki, Yohei, Sakura, Takaya, Inaoka, Daniel Ken, Fujine, Kiyotaka, Kita, Kiyoshi, Morita, Kouichi, Yasuda, Jiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846235/ https://www.ncbi.nlm.nih.gov/pubmed/33571909 http://dx.doi.org/10.1016/j.bbrc.2021.01.091 |
Ejemplares similares
-
Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022) -
5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022) -
Persistence of Neutralizing Antibody Against Dengue Virus 2 After 70 Years from Infection in Nagasaki
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2016) -
The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021) -
Ending tuberculosis by 2030: understanding the transmission
por: Pandey, Basu Dev, et al.
Publicado: (2023)